[Plaza-Díaz A] Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Juanes-Borrego A] Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. [Sanz-Lopez N] Emergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [González-Bueno J] Pharmacy Department, Hospital Dos de Maig Consorci Sanitari Integral, Barcelona, Spain. Central Catalonia Chronicity Research Group (C3RG), University of Vic-Central University of Catalonia (UVIC-UCC), Vic, Spain. [Fernández-Morató J] Pharmacy Department, Consorci Sanitari de Terrassa, Terrassa, Spain. [García-Peláez M] Pharmacy Department, Hospital General de Granollers, Granollers, Spain
Consorci Sanitari de Terrassa
2025-10-27T13:44:32Z
2025-10-27T13:44:32Z
2025-09-29
Drug-related problems; Emergency department; Older adults; Readmission; Secondary prevention
Problemas relacionados con medicamentos; Servicio de urgencias; Reingreso; Prevención secundaria
Problemes relacionats amb medicaments; Servei d'urgències; Reingrés; Prevenció secundària
Background/Objective: Drug-related problems (DRPs) are a common, potentially avoidable cause of emergency department (ED) use. In December 2022, our hospital integrated a pharmacist-led intervention into routine ED practice. This intervention comprised medication optimization, adherence counseling, and coordinated hand-off to primary care. We quantified 30- and 90-day reconsultations after discharge and explored factors associated with DRP-related revisits. Methods: A retrospective cohort of adults (≥18 years) who attended a tertiary ED (Barcelona, Spain). We included index DRP visits from 1 December 2022 to 30 June 2024. All received the bundle. Demographic, clinical, and pharmacotherapeutic data were extracted from the Catalan Shared Health Record; an independent committee classified revisits as a DRP or non-DRP. Predictors of 30-day DRP revisits were assessed with multivariable logistic regression. Results: Among 1247 patients (mean age 78.6 ± 16.2 years; 59.2% women; and median nine drugs), 120 (9.6%) reconsulted the ED within 30 days, and 194 (15.5%) within 90 days for any cause. DRP-specific rates were 30.8% (37/120) at 30 days and 26.3% (51/194) at 90 days; 81% and 80% of these revisits, respectively, involved a recurrence of the same DRP. The most frequent index DRPs were constipation (14.2%), gastrointestinal bleeding (9.2%), hypertension (8.3%), seizures (8.3%) and hyponatraemia (6.7%). An age ≥ 80 years independently predicted fewer 30-day DRP revisits (OR 0.32; 95% CI 0.13-0.79); hypertension and cognitive impairment were not significant after adjustment. Conclusions: In this single-arm implementation cohort, overall, 30-day ED reconsultations were 9.6% and about one-third were DRP-related, predominantly recurrences, and chiefly gastrointestinal bleeding and seizures. These descriptive findings should be interpreted cautiously given potential survivorship bias and residual confounding; the apparently lower risk among patients aged ≥ 80 years is hypothesis-generating and may reflect geriatric care pathways and caregiver engagement. Targeted post-discharge monitoring for high-recurrence DRPs may help reduce avoidable ED use, and future evaluations should test this in quasi-experimental or randomized designs.
Article
Versió publicada
Anglès
Hospitals - Serveis d'urgències; Medicaments - Efectes secundaris; Raonament basat en casos; HEALTH CARE::Health Care Facilities, Manpower, and Services::Health Services::Emergency Medical Services; DISEASES::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics::Epidemiologic Studies::Cohort Studies; ATENCIÓN DE SALUD::instalaciones, servicios y personal de asistencia sanitaria::servicios de salud::servicios médicos de urgencia; ENFERMEDADES::trastornos inducidos químicamente::efectos colaterales y reacciones adversas relacionados con medicamentos; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::características de los estudios epidemiológicos::estudios epidemiológicos::estudios de cohortes
MDPI
Journal of clinical medicine;14(19)
https://www.doi.org/10.3390/jcm14196907
Attribution-NonCommercial 4.0 International
https://creativecommons.org/licenses/by/4.0/
Articles científics - CST [139]
Articles científics - HG [170]